# Cardiovascular Risk and Menopause

> NEET-PG Obstetrics and Gynaecology notes on cardiovascular risk and menopause, covering lipid changes, HRT timing hypothesis and risk assessment in women.

- Canonical URL: https://prepelephant.com/topics/neet-pg/obstetrics-and-gynaecology/cardiovascular-risk-and-menopause
- Exam / course: NEET-PG · Subject: Obstetrics and Gynaecology
- Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team
- First published: 2026-10-14
- Last updated: 2026-10-14
- Reference basis: Williams Gynecology; Speroff's Clinical Gynecologic Endocrinology and Infertility; Harrison's Principles of Internal Medicine
- How to cite: "Cardiovascular Risk and Menopause", PrepElephant, https://prepelephant.com/topics/neet-pg/obstetrics-and-gynaecology/cardiovascular-risk-and-menopause

## Direct answer

Cardiovascular risk rises after menopause because falling oestrogen worsens the lipid profile, promotes central fat gain and removes protective effects on the blood vessels, and cardiovascular disease becomes the leading cause of death in women after menopause. The timing hypothesis proposes that hormone therapy started near menopause may protect the heart, whereas starting it many years later may increase risk, so individual risk assessment guides the decision.

## What you must remember

- **Lipid changes:** After menopause LDL cholesterol and triglycerides typically rise, and HDL cholesterol tends to fall.
- **Oestrogen effect:** Oestrogen has favourable effects on lipids, endothelial function and vascular tone, and its loss removes that protection.
- **Fat distribution:** Central and visceral fat accumulate after menopause, adding metabolic risk.
- **Timing hypothesis:** Benefit is suggested when hormone therapy starts near menopause, while late initiation in women with established vascular disease may increase risk.
- **Risk assessment:** Standard cardiovascular risk tools include age, blood pressure, lipids, diabetes, smoking and family history.
- **Premature menopause:** Early menopause, natural or surgical, is an independent cardiovascular risk factor.
- **Prevention:** Blood pressure, lipid control, diet, exercise and smoking cessation remain central at every stage.

## Matching hormone therapy to cardiovascular risk

The timing hypothesis is an interpretation of trial and observational data rather than a fixed rule, and sources differ in the cut-offs they use. The table gives the usual interpretation for common scenarios, and the timing relative to menopause should be read before the drug or the risk.

| Scenario | Usual interpretation | Practical implication |
|---|---|---|
| Started near menopause, under 60, no cardiovascular disease | Benefit or neutral | Hormone therapy may be considered for symptoms |
| Started more than about 10 years after menopause | Risk may outweigh benefit | Avoid starting for prevention |
| Established cardiovascular disease | Not used for prevention | Treat disease and risk factors |
| Premature menopause before 40 | Higher baseline risk | Hormone replacement generally advised until natural menopausal age |

Hormone therapy is individualised, so the table is a starting point for counselling rather than a decision rule. Blood pressure, lipids and smoking status should be recorded before any treatment is discussed, because a woman who starts therapy late may already have established vascular disease.

## Where the exam tries to catch you

Vignettes often test whether the student recognises the timing of therapy and the baseline cardiovascular status.

- **Trap:** Prescribing hormones to prevent heart disease in a woman with established disease. — **Correct:** Hormone therapy is not a cardiovascular prevention strategy in established disease, and the risk is greater.
- **Trap:** Stating that menopause itself causes heart disease. — **Correct:** Menopause lowers oestrogen and worsens risk factors, but overall risk depends on age and traditional factors.
- **Trap:** Treating lipid changes as the only risk. — **Correct:** Blood pressure, diabetes, smoking and family history all contribute, and risk tools include them.
- **Trap:** Assuming early menopause carries no extra risk. — **Correct:** Early menopause raises cardiovascular risk independently, so it deserves attention and counselling.

## Frequently asked questions

### Why does cardiovascular risk rise after menopause?
Cardiovascular risk rises after menopause because the loss of oestrogen worsens the lipid profile, promotes central fat gain and reduces protective effects on the blood vessels. The rise is gradual but substantial in women who already have other risk factors.

### What is the timing hypothesis for hormone therapy?
The timing hypothesis proposes that hormone therapy started near menopause may protect the cardiovascular system, whereas starting it many years later may increase risk. It is an interpretation of trial and observational data, and the cut-offs used in different sources vary.

### Which lipid changes occur at menopause?
LDL cholesterol and triglycerides typically rise after menopause, and HDL cholesterol tends to fall. This pattern favours atherosclerosis and is one reason lipid profiles should be checked in postmenopausal women.

### Does early menopause increase cardiovascular risk?
Yes, early menopause, whether natural or surgical, is an independent cardiovascular risk factor. Women with premature menopause therefore need cardiovascular risk assessment and counselling alongside decisions about hormone replacement.